EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Predicting human pharmacokinetics from preclinical data: absorption

Dong-Seok Yim iD, Suein Choi iD, Soo Hyeon Bae iD

Translational and Clinical Pharmacology · 2020 · 28 (3) · 126

DOI: 10.12793/tcp.2020.28.e14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational and Clinical Pharmacology, 2020. Verfasst von Dong-Seok Yim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, …. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Predicting the rate and extent of oral absorption of drugs in humans has been a challenging task for new drug researchers. This tutorial reviews in vitro and PBPK methods reported in the past decades that are widely applied to predicting oral absorption in humans. The physicochemical property and permeability (typically obtained using Caco-2 system) data is the first necessity to predict the extent of absorption from the gut lumen to the intestinal epithelium (Fa). Intrinsic clearance measured using the human microsome or hepatocytes is also needed to predict the gut (Fg) and hepatic (Fh) bioavailability. However, there are many issues with the correction of the inter-laboratory variability, hepatic cell membrane permeability, CYP3A4 dependency, etc. The bioavailability is finally calculated as F = Fa × Fg × Fh. Although the rate of absorption differs by micro-environments and locations in the intestine, it may be simply represented by ka. The ka, the first-order absorption rate constant, is predicted from in vitro and in vivo data. However, human PK-predicting software based on these PBPK theories should be carefully used because there are many assumptions and variances. They include differences in laboratory methods, inter-laboratory variances, and theories behind the methods. Thus, the user's knowledge and experiences in PBPK and in vitro methods are necessary for proper human PK prediction.

Schlagwörter

Stichwörter der Autor:innen

AbsorptionBioavailabilityHuman PK PredictionPBPK

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • PIPET (Pharmacometrics Institute for Practical Education and Training), College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Qfitter Inc., Seoul 06578, Korea.

ORCID-Profile: Dong-Seok Yim, Suein Choi, Soo Hyeon Bae

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Yim, D. S., Choi, S., & Bae, S. H. (2020). Predicting human pharmacokinetics from preclinical data: absorption. Translational and Clinical Pharmacology, 28(3), 126. https://doi.org/10.12793/tcp.2020.28.e14

Vancouver

Yim DS, Choi S, Bae SH. Predicting human pharmacokinetics from preclinical data: absorption. Translational and Clinical Pharmacology. 2020;28(3):126. doi:10.12793/tcp.2020.28.e14

BibTeX
@article{Yim2020,
  author = {Yim, Dong-Seok and Choi, Suein and Bae, Soo Hyeon},
  title = {Predicting human pharmacokinetics from preclinical data: absorption},
  journal = {Translational and Clinical Pharmacology},
  year = {2020},
  volume = {28},
  number = {3},
  pages = {126},
  doi = {10.12793/tcp.2020.28.e14}
}
Kostenlos starten →